QingSong Health (HKSE:02661) ROE %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02661 QingSong Health Corp HKSE:02661
18 GF Score
Price HK$7.02
! 2 Warning Signs
View Full Analysis

What is QingSong Health ROE %?

QingSong Health HKSE:02661 +2.18% 18 ROE % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 623 Healthcare Providers & Services companies, QingSong Health ranks worse than 160513.48% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. QingSong Health's annualized net income for the quarter that ended in Dec. 2025 was HK$-1,029 Mil. QingSong Health's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was HK$-65 Mil. Therefore, QingSong Health's annualized ROE % for the quarter that ended in Dec. 2025 was N/A%.

The historical rank and industry rank for QingSong Health's ROE % or its related term are showing as below:

HKSE:02661's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.88
* Ranked among companies with meaningful ROE % only.

QingSong Health  (HKSE:02661) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-1029.086/-64.697
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1029.086 / 1325.224)*(1325.224 / 1006.321)*(1006.321 / -64.697)
=Net Margin %*Asset Turnover*Equity Multiplier
=-77.65 %*1.3169*N/A
=ROA %*Equity Multiplier
=-102.26 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-1029.086/-64.697
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1029.086 / -1028.83) * (-1028.83 / 70.228) * (70.228 / 1325.224) * (1325.224 / 1006.321) * (1006.321 / -64.697)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0002 * -14.6499 * 5.3 % * 1.3169 * N/A
=N/A %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


QingSong Health ROE % Related Terms


QingSong Health ROE % Historical Data

* Premium members only.

The historical data trend for QingSong Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QingSong Health ROE % Chart

QingSong Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE %
0.00 Negative Equity Negative Equity 0.00

QingSong Health Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial 0.00 Negative Equity 0.00 Negative Equity 0.00

HKSE:02661 vs VEEV, BTSG, TEM: ROE % Comparison

For the Health Information Services subindustry, QingSong Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QingSong Health ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's ROE % distribution charts can be found below:

* The bar in red indicates where QingSong Health's ROE % falls into.


HKSE:02661
18GF Score
QingSong Health Corp HKSE:02661
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QingSong Health ROE % Calculation

QingSong Health's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-419.487/( (-1301.008+1107.18)/ 2 )
=-419.487/-96.914
=N/A %

QingSong Health's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-1029.086/( (-1236.574+1107.18)/ 2 )
=-1029.086/-64.697
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
QingSong Health (HKSE:02661) has a ROE % of 0.00% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QingSong Health and its competitors. According to the industry distribution chart, QingSong Health ranks #999999 out of 623 companies in the Healthcare Providers & Services industry.
Is QingSong Health's ROE % too high?
QingSong Health's current ROE % is 0.00%. Based on the distribution chart, QingSong Health ranks #999999 out of 623 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, QingSong Health ranks #999999 out of 623 companies for ROE %. This places QingSong Health in the lower half of its industry. The industry median ROE % is 5.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QingSong Health and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QingSong Health's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current ROE % of 0.00%. The current ROE % is 0.00%. QingSong Health's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current ROE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QingSong Health Business Description

Address No. 28 Andingmen East Street, 7th floor, Building F, Yonghe Mansion, Dongcheng District, Beijing, CHN
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score

Get the complete analysis for HKSE:02661

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.02
Price